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Abstract.  We have previously shown that aggregation 
of microbeads coated with N-CAM and Ng-CAM is 
inhibited by incubation with soluble neurocan,  a chow 
droitin sulfate proteoglycan of brain,  suggesting that 
neurocan binds to these cell adhesion molecules (Gru- 
met, M., A. Flaccus, and R. U. Margolis.  1993. J. 
Cell Biol.  120:815). To investigate these interactions 
more directly, we have tested binding of soluble 125I- 
neurocan to microwells coated with different glycopro- 
teins.  Neurocan bound at high levels to Ng-CAM and 
N-CAM, but little or no binding was detected to 
myelin-associated glycoprotein, EGF receptor, 
fibronectin, laminin,  and collagen IV.  The binding to 
Ng-CAM and N-CAM was saturable and in each case 
Scatchard plots indicated a high affinity binding site 
with a dissociation constant of ~1  nM.  Binding was 
significantly reduced after treatment of neurocan with 
chondroitinase,  and free chondroitin sulfate inhibited 
binding of neurocan to Ng-CAM and N-CAM.  These 
results indicate a role for chondroitin sulfate in this 
process, although the core glycoprotein also has 
binding activity. The COOH-terminal half of neurocan 
was shown to have binding properties essentially iden- 
tical to those of the full-length proteoglycan. 
To study the potential biological functions of neuro- 
can, its effects on neuronal adhesion and neurite 
growth were analyzed.  When neurons were incubated 
on dishes coated with different combinations of neuro- 
can and Ng-CAM, neuronal adhesion and neurite 
extension were inhibited.  Experiments using anti-Ng- 
CAM antibodies as a  substrate also indicate that neu- 
rocan has a direct inhibitory effect on neuronal adhe- 
sion and neurite growth,  lmmunoperoxidase staining 
of tissue sections showed that neurocan,  Ng-CAM, 
and N-CAM are all present at highest concentration in 
the molecular layer and fiber tracts of developing cere- 
bellum.  The overlapping localization in vivo, the mo- 
lecular binding studies, and the striking effects on neu- 
ronal adhesion and neurite growth support the view 
that neurocan may modulate neuronal adhesion and 
neurite growth during development by binding to neu- 
ral cell adhesion molecules. 
I 
NTERACTIONS of cells with proteins in the extracellular 
matrix and on the surfaces of other cells are important 
for cell adhesion,  cell migration,  and transmembrane 
signalling.  These processes are mediated by plasma mem- 
brane proteins that include cell adhesion molecules (CAMs) I 
and receptors for other proteins such as extracellular  matrix 
(ECM) proteins and growth factors.  Whereas CAMs have 
been found to promote cell adhesion and cell migration, 
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different ECM proteins may either promote or inhibit these 
processes in different situations  (Hynes and Lander,  1992; 
Edelman and Crossin, 1991; Reichardt and Tomaselli,  1991; 
Schwab et al., 1993). For example, whereas fibronectin pro- 
motes adhesion and migration  of many types of cells, tenas- 
cirdcytotactin  can either support or inhibit neurite growth in 
culture,  depending  on the conditions  (Crossin  et al.,  1990; 
Lochter et al.,  1991). 
Chondroitin  sulfate proteoglyeans have been found to be 
potent inhibitors of cell adhesion,  cell migration,  and neurite 
growth (Ruoslahti,  1989; Wight et al.,  1992; Margolis and 
Margolis,  1993). They are found predominantly  in the ECM 
of various tissues and their expression  during  development 
in regions such as neural crest cell pathways and the spinal 
cord is consistent with the concept that they may act as bar- 
tiers for cell migration  (Perris et al., 1991; Oakley and Tos- 
hey, 1991; Snow et al., 1990a,b; Pindzola et al., 1993). Ini- 
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the central nervous system were performed using proteogly- 
cans isolated from other tissues from which they could be 
purified more easily than  from brain (Snow et al.,  1990a, 
1991). Although  the observed effects have been attributed 
primarily to the chondroitin  sulfate component, our recent 
studies (Grumet et al., 1993) indicate that the core glycopro- 
teins of neurocan and phosphacan (Maurel et al., 1994; pre- 
viously designated  the 3F8 proteogiycan) are potent inhibi- 
tors of neuronal  adhesion.  This emphasizes  the importance 
of determining  the primary  structures of brain proteogiy- 
cans,  since this  structural information  will facilitate  more 
detailed  investigations  of their  molecular mechanisms  of 
action. 
Neurocan  (previously designated  1D1) is  an  ,~500-kD 
chondroitin  sulfate proteogiycan of rat brain which is de- 
velopmentally regulated with respect to its molecular size, 
concentration,  carbohydrate  composition,  sulfatlon,  and 
immunocytochemical localization  (Ranch  et al.,  1991). A 
5.2-kb composite sequence of overlapping  cDNA clones 
contains an open reading frame of 1,257 amino acids which 
encodes a 136-kD protein (Rauch et al., 1992). The deduced 
amino acid sequence reveals a signal peptide followed by an 
Ig domain, tandem repeats characteristic  of the hyaluronic 
acid-binding region of aggregating  proteoglycans,  and an 
RGDS sequence.  The COOH-terminal portion has ,'-60% 
identity  to regions in the COOH termini of two other pro- 
teoglycans,  versican  and  aggrecan,  whereas  the  central 
595-amino acid portion of neurocan has no homology with 
other reported protein sequences.  The proteoglycan isolated 
from adult brain with the  11)1 monoclonal antibody rep- 
resents the COOH-terminal half of neurocan and is therefore 
designated  neurocan-C.  A probe corresponding to a region 
of neurocan having no homology with versican or aggrecan 
hybridized specifically with a single band at 7.5 kh on North- 
ern blots of mRNA from both 4-d and adult rat brain. This 
indicates that neurocan-C of adult brain, containing a 68-kD 
core protein,  is generated by a developmentally regulated in 
vivo proteolytic processing of the 136-kD species which is 
predominant  in early postnatal brain (Ranch et al.,  1992). 
We have  recently investigated  interactions  of neurocan 
with neurons and the neural CAMs, Ng-CAM, and N-CAM 
(Grumetet al., 1993). Both of these CAMs have been impli- 
cated in developmental  processes in nervous tissue, includ- 
ing  cell adhesion, neuronal  migration,  and axonal  growth 
(Edelman  and Crossin,  1991; Grumet,  1992; Doherty and 
Walsh,  1992). Ng-CAM and N-CAM show some structural 
similarities in that they are ,~25 % identical in amino acid se- 
quence, they both contain extracellular  regions with Ig-like 
and fibronectin-like  domains,  and they share at least one 
carbohydrate determinant that is recognized by monoclonal 
antibodies  HNK-1 and NC-1 (Burgoon et al., 1991; Grumet 
et al.,  1984b;  Kruse et al.,  1984).  Each CAM can bind 
homophilically,  as demonstrated by the  ability  of CAM- 
coated  fluorescent  beads  (Covaspheres)  to  self-aggregate 
(Grumet and Edelman, 1988; Hoffman and Edelman,  1983). 
It was found that the aggregation of Covaspheres coated with 
either Ng-CAM or N-CAM was strongly inhibited by intact 
neurocan,  and  by the  core  glycoproteins  resulting  from 
chondroitinase  treatment  of both neurocan and neurocan-C 
(Grumet et al., 1993). Neurocan also inhibited adhesion of 
neurons to Ng-CAM when mixtures of these proteins were 
adsorbed to polystyrene dishes. On the other hand, in a short 
term binding  assay that allows one to detect interactions  of 
cells with proteins that inhibit cell spreading (Friedlander et 
al., 1988), direct adhesion of neurons to neurocan core pro- 
tein could be demonstrated (Grumet et al.,  1993). 
These results indicate that neurocan can bind to neurons, 
and raise the possibility that Ng-CAM and N-CAM may be 
heterophilic  ligands for neurocan.  The ability of chondroitin 
sulfate  proteogiycans  of brain to inhibit  cell adhesion  to 
CAMs may be an important mechanism  for modulating cell 
adhesion  and migration  in  the nervous  system.  We have 
therefore directly studied neurocan binding  to CAMs and 
other cell surface or ECM molecules, as well as its effects 
on neuronal adhesion and neurite outgrowth.  Neurocan was 
chosen for these studies because it is one of the most abun- 
dant chondroitin  sulfate proteogiycans  of developing  brain 
(Ranch et al.,  1991) and its primary structure has recently 
been determined (Rauch et al.,  1992). 
Materials and Methods 
Proteins and Antibodies 
Ng-CAM and N-CAM were purified from 14-d embryonic chicken braim 
by immuneaflinity chromatography using monoclonal antibodies 10F6 and 
3(32 that  specifically recognize Ng-CAM, and monoclonal anti-N-CAM 
No.  1, respectively (Grumet and Edelman,  1988). Nerve growth factor- 
inducible large external glycoprotein (NILE)/L1 was purified from 7-¢1  post- 
natal rat brain using a combination of other anti-Ng-CAM monocional anti- 
bodies (2C2 and 19H3) that recognize the cytoplasmic region of Ng~.AM, 
which  is highly  conserved  between  chicken  Ng-CAM  (Burgoon et al., 
1991), mouse L1 (Moos et al., 1988), and rat NILE (Prince et al., 1991). 
Because of extensive similarities  between these proteins in structure,  ex- 
pression pe~erus,  and function (Gnun~, 1992; Sonderegger and Rathjen, 
1992), we refer to them generally as Ng-CAM/L1/NILE,  and we refer to 
Ng-CAM and LI/NILE when discussing experiments using the particular 
protelm from chick and rat, respectively. 
The L1/NILE protein purified from detergent extracts of rat brain mem- 
branes contains on SDS-PAGE two major components of Mr 200,000 and 
140,000 and small amounts of a componetu of Mr 80000.  PolycloMI anti- 
bodies a  eainst human LI (kindly provided by Dr. John Hemperly, Becton 
Dickinson,  Research Triangle  Park,  North  Carolina)  recognized  the Mr 
200000  and  140,000 species  on  immtmoblots,  confirmin  8  that  it  is 
NILE/L1. The 5B8 monoclonal antibody used to purify N-CAM from 7-d 
postnatal  rat brain and for immuno~oc~  WaS ~  from the 
Developmental Studies Hybridoma Bank (maintained by the Del~Unent of 
Pharmacology and Molecular Science, Johns Hopkins University School of 
Medicine, Baltimore, MD, and the Department of Biology, University of 
Iowa, Iowa  City, IA, under contract NOI-HD-6-2915  from the N/H). This 
antibody recognizes cytoplasmic regions of N-CAM. When the rat N-CAM 
was resolved on SDS-PAGE and stained with Coomassie blue, the charac- 
teristic heterodisperse pattern  of polysialylated N-CAM was observed. 
Neurocan was isolated aud analyzed as described previously (Ranch et 
al.,  1991; Grumet et al.,  1993). Briefly, brains  of 7-d or 2- to 3-too-old 
Sprague-Dawley rats  were extracted  with PBS, and protvoglyr,  aus were 
purified by ion exchange chromatography  and gel filtration (Kiang et al., 
1981). Neurocan was purified by immqnoa~nity chromatography using the 
1D1 monoclonal antibody (Rauch et al., 1991). Rat chondrosarcoma chow 
droitin sulfate proteoglycan (aggrecan) was isolated by CsCI density gra- 
dient centrifugafion (Faltz et al., 1979). For studies of the core proteins, 
proteoglycans were digested for 45-60 rain at 37°C with protease-free chon- 
droJ~nase ABC (scikagaku America Inc., Rockville, MD) in 100 mM Tris- 
HCI buffer (pH 8.0 at 37°C) conta|nlng 30 mM sodium acetate, and com- 
pleteness of digestion was confirmed by SDS-PAGE (Ranch et al., 1991); 
control treatments were performed  at 37°C in the absence of enzyme. 
Myelin-associated giycoprotein (M~J3) (a recombinant  form including 
the ectudomain; Pedraza et al., 1990) and epidermal growth factor receptor 
(a recombinant,  soluble,  extracellular,  ligand-bi~ina form; Lax et el., 
1991) were kind gifts from Drs. J. L. Salzer and L Schiessinget (New York 
University Medical Center, New York), respectively. Commercial reagents 
included laminin and type I and IV collagens (Collaborative Research, Bed- 
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(ICN Biomedical, Lisle, IL). Sturgeon notochord chondroitin sulfate, con- 
sisting of 80% chondroitin  4-sulfate and 20% chondroitin 6-sulfate, was ob- 
tained from Seikagaku America Inc.  (P~ckville,  MD). 
Monoclonni antibodies against chicken Ng-CAM (C,-rumet  and Edelman, 
1984) and the 1D1 monoclonal antibody to neurocan (Ranch et al.,  1991) 
have been described  previously.  A  monoclonal antibody  (CL-300)  to 
calbindin-D was  obtained from Sigma Chemical Co.  (St.  Louis,  MO). 
When IgG was used, it was precipitated from ascites fluid with ammonium 
sulfate and fiu'ther purified on DE-52 columns. 
Radioligand Binding  Assay 
Proteoglycans were labeled to a  specific  activity of 2.5-6  ×  10  TM cpm/ 
mole with 1251 by the lactopemxidase/glucuse  oxidase method using En- 
zymobeads (BioRad Laboratories, Richmond, CA). Typically, 50/~g of  pro- 
rein were labeled per reaction, and free iodine was removed by gel filtration 
on a PD-10 column (Pharmacia Fine Chemicals, Piscataway, NJ). Binding 
assays were performed essentially as described by Zisch et al. (1992).  1-30 
#g/ml of soluble proteins in binding buffer (16 mM Tris, pH 7.2, 50 mM 
NaCI, 2 mM CaCI2, 2 mM MgCI2, 0.02% NAN3) were adsorbed to remov- 
able Immunlon-2 wells (Dynatech, Chantilly, VA) by overnight incubation 
at room temperature. Unbound proteins were removed with three washes 
in binding  buffer/0.02 % Tween 20, and the wells were blocked by incubation 
with I mg/ml heat*treated BSA in binding buffer. Wells were then emptied 
and 50/~l/well of labeled proteins or mixtures of labeled and unlabeled pro- 
teins (in binding buffer containing 1 mg BSMml) were incubated for 2 h 
at room temperature. Unbound proteoglycan  was removed by four washes 
with TBS (50 mM Tris, pH 7.2, 150 mM NaCI)/0.02 % Tween 20, and radio- 
activity bound to wells was determined with a gamma counter. Some experi- 
ments were also performed in isotonic buffer (50 mM Tris, pH 7.2, 150 mM 
NaCI, 2 mM CaCI2, 2 mM MgCI2, 0.02%  NAN3). Scatcbard  plots were 
generated and dissociation constants were determined using the Macintosh 
version of the Ligand program (Munson and Rodbard,  1980). 
Cell  Adhesion  Assays 
250 p.1 of DMEtITS  + containing 6  ×  105 cells were deposited in the cen- 
tral region of 35 mm polystyrene dishes that had been coated with proteins. 
Following incubation for 80 rain at 37°C,  unattached cells were removed 
by washing with PBS and the remaining cells were fixed with 3.5% forma- 
lin.  Attached cells  were  counted  under a  microscope  at  200×  mag- 
nification. 
Neurite Growth 
105 brain cells were incubated for 2 d under the same conditions used for 
cell adhesion assays,  and were fixed  with formalin. Neurite length was 
defined as the distance between the furthest removed neurite tip and the cell 
body. Quantitation was done under phase contrast microscopy with the help 
of a measuring eyepiece. 
lmmunocytochemistry 
The immunocytochemical localization of neurocan, NILE/LI, and N-CAM 
was performed on sagiRal Vibratome sections of 7-d rat cerebellum using 
the 1D1, 2C2, and 5B8 monoclonal antibodies, respectively. Rats were per- 
fusion fixed with picric acid-paraformaldehyde-glutaraldeh~xie,  and sec- 
tions were stained with peroxidase-conjugated  second antibody as described 
previously (Rauch et al.,  1991). 
Analytical Methods 
Proteins were resolved on SDS-PAGE (Laemmfi,  1970) and were either 
transferred to nitrocellulose and detected using antibodies (Grumet et al., 
1984/7; Towbin et al., 1979), or stained with Coomassie blue. Radiolabeled 
proteins were detected by autoradiography,  and protein concen~tlions were 
determined using either the Lowry (for neurocan) or the Bradford protein 
assay  (Bio-Rad  Laboratories). The concentration of aggrecan was deter- 
mined gravimetrically. 
Cells 
Dissociated cells were prepared essentially as described previously (Brack- 
enbury et al.,  1981). In brief, 9-d chick embryo brains were treated with 
trypsin/EIYl'A (GIBCO BRL, Gaithersburg, MD) followed by trimration in 
DME (GIBCO BRL) containing 10% fetal calf serum and 50 ~g/mi DNase 
I (Worthin~on Biochem. Corp.,  Freehold, NJ).  The cells were washed 
twice with DME/YfS + (Collaborative Research Inc., Waltham,  MA) and 
once by centrifugation through a 3.5 % BSA/PBS step gradient. 
Substrates 
Substrates for cell adhesion and neurite growth assays were arranged in a 
circular array (,'-l-cm diam) of 8 to 12 small circular regions of polystyrene 
dishes (Falcon 1007 and 1008; Becton Dickinson, Lincoln Park, NJ) that 
were coated with adsorbed proteins. Coated regions were prepared by in- 
cubating 1.5-/d droplets of protein solutions in a humidified chamber for 
30 vain (Friedlander et al., 1988). After removing the droplets by suction, 
the dishes were washed three times with PBS and blocked with 1% BSA. 
For double coats,  the first solution was applied and washed as described 
above,  except  that no blocking step was performed. Following  the third 
wash, the second solution was applied as described above,  including the 
blocking step. Thus, protein in the second solution could bind both to the 
plastic and to the first adsorbed protein. For quantitative determination of 
protein binding to the substrate, radiolabeled proteins were incubated with 
dishes using the same materials and procedures used for the cell assays. Af- 
ter the final wash, the dishes were dried, their walls removed with pliers, 
and the bottoms of the dishes were exposed to a Phosphorimnger screen 
(Molecular Dynamics,  Inc.,  Sunnyvale,  CA)  to  determine the  relative 
amounts of radioactivity in the central region of each spot by using interac- 
tive software (L,  nageQuant; Molecular Dynamics, Inc.). Absolute values of 
bound protein were obtained by comparing the relative values with the total 
radioactivity adsorbed to a similar set of spots that were dried completely, 
without prior washing.  For  measuring total  radioactivity,  this method 
yielded results similar to those obtained with a gamma counter.  However, 
for measuring the surface density of a second adsorbed protein, the Phos- 
pbo~anager method is more accurate because it allows one to specifically 
measure the radioactivity confined to precoated areas. 
Results 
Binding of Neurocan to Ng-CAM and N-CAM 
Binding of neurocan to various cell surface proteins includ- 
ing neural CAMs and ECM proteins was determined using 
a radioligand binding assay (Fig.  1). Both rat neurocan and 
neurocan-C bound to chicken Ng-CAM and to its presumed 
rodent homologue NILE/L1  (Grumet,  1992;  Sonderegger 
and Rathjen,  1992). Neurocan also bound to N-CAMs from 
chicken and rat. These results suggest that the proteoglycan 
binding domains in Ng-CAM  and N-CAM have been con- 
served during the evolution of avian and mammalian species. 
To analyze the specificity of the binding, we tested whether 
neurocan binds to other coil surface proteins that were avail- 
able to us including MAG and the: epidermal growth factor 
receptor, as well as extracollular matrix components that can 
modulate neuronal adhesion or neurite outgrowth. Neurocan 
bound weakly to collagen I and not at all to MAG, collagen 
IV, or EGF receptor. Under our standard  assay conditions 
(wells coated with proteins at a concentration of 1,25 #g/ml) 
neurocan did not bind to laminin but binding (9%  of total 
counts) was detected when a higher laminin concentration 
(10/~g/ml) was used. The fraction of neurocan that bound 
specifically to Ng-CAM was consistently ,020-25 %, with a 
signal to background ratio as high as 65:1.  The percent of 
neurocan bound to N-CAM  was usually lower and varied 
to  a  greater  extent  between  experiments,  ranging  from 
,08-15%  bound with a  signal to background ratio of 18- 
20:1.  By  comparison,  lz~I-labeled aggrecan,  a chondroitin 
sulfate  proteoglycan  isolated  from  rat  chondrosarcoma, 
bound very weakly to Ng-CAM and N-CAM (Fig.  1), sug- 
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Figure 1. Binding of neurocan and aggrecan to CAMs and extracel- 
lular  matrix  proteins.  Removable  wells  of 96-well  plates  were 
coated with unlabeled proteins (1.25 #g/ml) and incubated with 
nq-labeled  proteins  ('~160,000 cpm).  The fraction of the input 
bound to the different  substrates  is given as a percentage. Non- 
specific binding to BSA was also determined, and specific binding 
(percent bound) is calculated as total minus nonspecific  binding. 
Specific activities  in the experiments  shown here were 2.5-2.9  × 
10  ~s cpm/mole. All values are means of duplicate  determinations 
+SEM. EGF-R, epidermal growth factor receptor. 
gesting  that  the  interactions  between  neurocan  and  these 
neural CAMs depend upon structural domains in neurocan 
that  are  not  present  in  this  related  proteoglycan,  or  are 
masked by  its  much larger  number  of chondroitin  sulfate 
chains. 
The radioligand binding assays described above were per- 
formed in buffers containing 50 mM NaC1. This hypotonic 
buffer yielded higher signal to background ratios than incu- 
bation in buffer with  150 mM NaCI. At physiological salt 
concentration, binding of  neurocan to Ng-CAM and N-CAM 
was diminished by 35-60%,  and the binding to collagen I 
was reduced to baseline levels (Fig. 2). These results suggest 
that in vivo neurocan may not bind to collagen I but that it 
could bind to the neural CAMs. Because the amounts of neu- 
rocan that we can isolate from rat brain are limited, we chose 
to perform most saturation and inhibition experiments using 
the hypotonic conditions. 
To investigate the reversibility of binding of neurocan to 
Ng-CAM, a kinetic analysis of the dissociation of neurocan 
was performed.  Labeled neurocan or neurocan-C were al- 
lowed to bind to Ng-CAM, free labeled molecules were re- 
moved,  and the amount of bound proteoglycan was deter- 
mined as a function of  time under two conditions. Wells were 
incubated either in the presence of 5 ~g/ml of  unlabeled pro- 
teoglycan (Fig. 3 A) or in large amounts of buffer (Fig. 3 B). 
Binding was reversible under both conditions, although the 
time required to reduce the binding to half the initial value 
was  shorter  in  the  presence  of  unlabeled  proteoglycan 
(tl/2 -  20-30 rain) than in the presence of excess buffer (ti,2 
4 h). Similar results were observed for the binding of neu- 
rocan to N-CAM (data not shown). 
Figure 2. Binding of  neurocan to CAMs and collagen I under hypo- 
tonic and isotonic conditions.  The hypotonic and isotonic buffers 
were as described in Materials  and Methods. Labeled proteogly- 
cans were applied  at an average of 160000 cpm/well. Values are 
means of  duplicate determinations;  error bars represent mean devi- 
ations. 
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Figure 3. Reversibility of  binding of  neurocan to Ng-CAM. Binding 
of 125I-neurocan and  nq-neurocan-C  to  Ng-CAM-coated wells 
was performed as described in Materials and Methods. Following 
the  removal  of free proteoglycan, wells  were incubated  with  5 
/~g/ml unlabeled neurocan or neurocan-C in 100/tl of  isotonic bind- 
ing buffer (A), or in 40 ml of isotonic binding buffer without added 
proteoglycan (B). At the indicated  times,  the amounts of labeled 
pmteoglycan remaining in the wells were determined,  Experimen- 
tal points correspond to specific binding and are averages (n =  2). 
Bars represent mean deviations. 
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Figure  4.  Saturation curves and Scatchard plot analysis of 125I- 
labeled neurocan (A) and neurocan-C (B) binding to Ng-CAM. 
Binding values represent specific binding (total cpm bound minus 
cpm bound to BSA). Neurocan was tested at 0.5-50 rig/well (6.8 
×  10  Is cpm/mole), and neurocan-C at 0.2-37 ng/well (4.8 x  10  Is 
cpm/mole). Points in the saturation curve are averages of duplicate 
determinations, and the error bars represent mean deviations. 
To analyze further the binding of neurocan to Ng-CAM 
and N-CAM,  saturation experiments were performed with 
increasing amounts of labeled proteoglycan. Binding of neu- 
rocan and neurocan-C to both Ng-CAM (Fig. 4) and N-CAM 
(Fig. 5) was saturable in butters containing 50 mM NaC1, 
indicating  the presence of a  limited number of neurocan 
binding sites on Ng-CAM and N-CAM. Scatchard analysis 
of these data (Scatchard, 1949) yielded linear plots for bind- 
ing to Ng-CAM and N-CAM,  indicating a  single class of 
binding sites for both neurocan and neurocan-C. In all cases, 
the dissociation constants derived from the plots were quite 
similar  (ranging  from 0.42  to 0.84  nM),  indicating  high 
affinity binding  that  is  compatible with  specific receptor 
binding (Schlessinger, 1988). Comparable values were ob- 
tained for the binding of neurocan and neurocan-C to Ng- 
CAM  in the presence of isotonic buffer (1.8 and 5.3  nM, 
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Figure 5. Saturation curves and Scatchard analysis of t~I-labeled 
neurocan (A) and neurocan-C  (B) binding to N-CAM. Binding 
values represent  specific binding (total  ¢pm bound minus cpm 
bound  to  BSA). Neurocan  was  tested  at  0.4-40  ng/well  and 
neurocan-C at 1-60 rig/well. Points in the saturation curve are the 
averages of duplicate determinations, and the error bars represent 
mean deviations. 
respectively). For both Ng-CAM and N-CAM,  the maxi- 
mum number of binding sites (B~,J corresponded to ,~1/5 
the number of CAM molecules coating the wells, which was 
determined independently. The difference  between these val- 
ues may be related to the observation that both of these neu- 
ral CAMs behave as supramolecular complexes of >~10  ~ D, 
as determined by density gradient sedimentation of the de- 
tergent solub'dized proteins (Becker et al.,  1989; Grumet, 
1992). It is possible that these complexes may constitute uni- 
tary binding sites. 
The specificity of binding of neurocan to these neural 
CAMs was also investigated in inhibition expe  "runents. Sub- 
strate-bound CAMs and labeled ligands were first incubated 
with increasing concentrations of unlabeled molecules in- 
cluding neurocan, aggrecan, chondroitin sulfate, chondroi- 
tin  sulfate  disaccharides  (resulting  from  chondroitinase 
treaunent of the pmteoglycans) and fibronectin, and binding 
of ~2~I-neurocan was then measured. In these experiments, 
binding of nSI-neurocan to Ng-CAM was inhibited by solu- 
ble neurocan in a concentration-dependent manner (Fig. 6). 
Significant concentration-dependent inhibition of neurocan 
binding to  Ng-CAM  and  N-CAM  was  also  produced by 
aggrecan, a rat cartilage proteoglycan having a high concen- 
tration of chondroitin sulfate, and by free chondroitin sulfate 
chains (Fig. 6).  The disaccharide composition of the stur- 
geon notochord chondroitin sulfate used in these inhibition 
experiments (80% chondroitin 4-sulfate and 20% chondroi- 
tin 6-sulfate) is identical to that of neurocan in early postna- 
tal brain (Rauch et al.,  1991).  However, sulfated disaccha- 
rides  had  very little  effect on  the  binding  of neurocan, 
demonstrating that intact chondroitin sulfate chains are re- 
quired to inhibit proteoglycan  binding to CAMs. In the same 
assay, fibronectin also had very little effect. Using the same 
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Figure 6. Binding of nSI-labeled neurocan to Ng-CAM in the pres- 
ence of  other soluble molecules. Wells coated with Ng-CAM were 
incubated with  n5Llabeled ne~  (160,000 cpm/well) in the 
presence of unlabeled neurocan (.), aggrecan (.), cbondroitin sul- 
fate (0), chondroitin sulfate disaccbarides (~), and fibmneotin (o) 
at the concentrations indicated. Specific binding of  neurocan to Ng- 
CAM in the absence of soluble molecules corresponds to 0% inhi- 
bition; background level of  neurocan binding to BSA defines 100% 
inhibition. Values are the averages of duplicate determinations; er- 
ror bars represent mean deviations. It should be noted that in terms 
of moles of chondroitin sulfate, neurocan (which contains only 
20% by weight of chondroitin sulfate) is a much better inhibitor 
than aggrecan ('~,80% chondroitin sulfate) or free chondroitin sul- 
fate chains. 
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patterns of inhibition for binding of neurocan to N-CAM 
and for binding of neurocan-C to Ng-CAM and to N-CAM 
(data not shown). The results suggest that chondroitin sulfate 
chains, which constitute ,~20 % by weight of neurocan, are 
important in the binding of neurocan to the neural CAMs. 
To analyze more directly the role of chondroitin sulfate 
chains in interactions of neurocan with neural CAMs, we 
compared the binding of native and chondroitinase-trcated 
neurocan to Ng-CAM (Fig. 7 A) and N-CAM (Fig. 7 B). 
Chondroitinase treatment reduced binding of neurocan and 
neurocan-C  to  Ng-CAM  by  '~70%,  and  to  N-CAM  by 
,,o80%, in both hypotonic (Fig. 7) and isotonic buffers (data 
not shown). Heat-treated proteoglycans retained the ability 
to bind to the CAMs, although at levels that were lower than 
those of controls.  However,  chondroitinase treatment fol- 
lowed by  heat  treatment  further  reduced  the  binding  to 
nearly background levels.  Since it is known that glycosyla- 
t.ion can protect proteins from denaturation (Oh-eda et al., 
1990), the modest effect of heat treatment on the binding ac- 
tivity of  the intact proteoglycan may be due to this phenome- 
non. These results are consistent with the involvement of 
chondroitln sulfate chains on neurocan in binding to Ng- 
CAM and N-CAM. Nevertheless, the data also indicate that 
the core protein of neurocan retains binding for Ng-CAM 
and  N-CAM  even  in  the  absence  of chondroitin  sulfate 
chains. 
Overlapping Localization of  Neurocan, Ng-CAM, 
and N-CAM in Developing  Brain 
If  the interactions between neurocan and neuronal CAMs are 
biologically significant, one would expect these molecules to 
appear in close proximity at certain times during develop- 
ment. The ability to isolate by immunoaffinity  chromatogra- 
phy significant  amounts of  neurocan (using mAb ID1) as well 
as NILE/L1 (using anti-Ng-cAM mAbs 2C2 and 19H3) and 
N-CAM (using mAb 5B8) from 7-d postnatal rat brain is evi- 
dence that all these proteins are present at this stage of devel- 
opment (see Materials and Methods). To determine the his- 
tological localization of these proteins, specific monoclonal 
antibodies were used for immunoperoxidase staining of sec- 
tions of early postnatal rat cerebellum. The staining with 
monoclonal antibodies against these three molecules was 
similar insofar as it was strongest in the molecular layer and 
in the deeper layers of the cerebellum (Fig. 8). Examination 
at higher magnification (Fig. 9) confirmed that strong stain- 
ing was associated with regions containing bundles of axons 
such as in the molecular layer and fiber tracts. This pattern 
of staining is in sharp contrast to that observed with other 
antibodies such as to calbindin, which specifically labeled 
Purkinje ceils and their dendrites projecting into the molecu- 
lar layer (Fig. 9). This general staining pattern for neurocan, 
Ng-CAM, and N-CAM was also observed in 4-,  I0-, and 
14-d postnatal brain (data not shown), and is characteristic 
of  several  neural  cell  adhesion  molecules  (Rathjen  and 
Schachner, 1984; Rathjen et al., 1987a, b; Pollerberg et al., 
1985).  Overlapping staining of these CAMs and neurocan 
was also seen prenatally (in E13 and E16 brain and spinal 
cord),  whereas  quite  different staining patterns  were ob- 
served using monoclonal antibodies against unrelated pro- 
teins such as glial fibrillary acidic protein (Flad, M., and 
R. K. Margolis, unpublished results). 
Figure 7. Effects  of chondroitinase and heat treatment on the bind- 
ing of neurocan to Ng-CAM and N-CAM. Control treated pro- 
teoglycans  were incubated at 37°C for 2 h in chondroitlna~ buffer, 
and heat treatment was for 15 rain at 95°C. Chondroitinase treat- 
ment (Ch-ase) and the radioligand binding assay  were performed 
as described in Materials and Methods. nSI-labeled  neurocan was 
used at 55,000 cpm/well. Values are averages of duplicate determi- 
nations, and error bars are mean deviations. 
Effects of  Neurocan on Neuronal Adhesion to Ng-CAM 
We previously showed, using a  short-term (,,ol  min) cen- 
trifugation adhesion assay,  that neurons  attach to plastic 
coated with neurocan, whereas using a medinm-term assay 
(,~1 h) under the force of gravity, neurons do not attach to 
a neurocan substrate or to substrates containing both neuro- 
can and Ng-CAM (Grurnet et al., 1993). Although rat neuro- 
can contains an RGDS sequence (Rauch et al.,  1991), this 
sequence may not be functionally  active insofar as a GRGDSP 
peptide (at 100 ttg/ml) does not inhibit the binding of chick 
neurons to neurocan in the centrifugation assay (Flad, M., 
and R. K. Margolis, unpublished results). 
Based on our finding that neurocan binds to Ng-CAM, we 
sequentially adsorbed two different proteins to polystyrene 
dishes and then tested the substrate for neuronal adhesion. 
To help interpret the results, we also determined the amounts 
of protein adsorbed to the dish for the various combinations 
of  protein  concentrations  and  coating  orders  used  (see 
Materials and Methods). When individual proteins were ad- 
sorbed to the dish, neurons attached strongly to Ng-CAM 
and  anti-Ng-CAM  Ig,  weakly to  N-CAM,  negligibly to 
BSA, and not at all to neurocan. Because of the weak neu- 
ronal adhesion to N-CAM, it was omitted from the double 
coating experiments. To analyze direct effects of neurocan on 
neurons, we used a monoclonal anti-Ng-CAM Ig as a per- 
The  Journal  of  Cell  Biology,  Volume 125,  1994  674 Figure 8. Immunoperoxidase staining of 7-d postnatal rat cerebellum with antibodies to Ng-CAM, neurocan, and N-CAM. (A) mAb 2C2, 
which recognizes a cytoplasmic region that is highly conserved between avian Ng-CAM and mammalian NILE/LI; (B) mAb 1131 to neuro- 
can; (C) mAb 5B8 to N-CAM. No staining was seen with supernatant from a hybridoma that does not produce antibodies to brain antigens. 
Whereas  all three antibodies stained long processes  in the fiber tracts,  antibodies against neurocan also intensely stained some regions 
(B, parallel arrows) surrounding the fiber tracts which were strongly stained with anti-Ng-CAM mAb 2C2. The anti-N-CAM monoclonal 
antibody recognizes the cytoplasmic region of N-CAM, and therefore revealed only the larger N-CAM species whose expression pattern 
in developing cerebellum parallels that of Ng-CAM/L1/NILE (Pollerberg et al.,  1985). EGL, external granule cell layer; ML, molecular 
layer; F~, fiber tract.  Bar, 200 #m. 
missive substrate that does not interact with neurocan. Neu- 
rons  bound  well  to  dishes  coated  with  anti-Ng-CAM  Ig 
(Table I) even after blocking with  a  large excess of BSA 
(Materials and Methods). Dishes coated first (protein 1) with 
BSA and then (protein 2) with anti-Ng-CAM Ig were also 
able  to  support  neuronal  attachment.  Coating  first  with 
anti-Ng-CAM Ig and then with neurocan inhibited neuronal 
adhesion.  The inhibition was most apparent at lower den- 
sities  of bound  anti-Ng-CAM  Ig.  In  addition,  substrates 
coated first with neurocan and then with anti-Ng-CAM Ig 
did not support neuronal adhesion. Inhibition occurred even 
though anti-Ng-CAM Ig was present at densities that sup- 
ported significant levels of neuronal attachment in the ab- 
sence of neurocan.  For example, neurons adhered to anti- 
Ng-CAM (0.25 rig/ram  2) when it was coated following BSA, 
but no adhesion was detected when even greater amounts of 
anti-Ng-CAM (0.42 ng/mm  2) were coated following neuro- 
Figure 9. High magnification views of immunoperoxidase staining 
of 7-d postnatal  rat cerebellum.  Staining  was performed as de- 
scribed in Fig. 8 and photographed  at high magnification to com- 
pare staining in different lamina of  the cerebellum using antibodies 
to Ng-CAM/NILE/LI (2C2), neurocan (1D1), N-CAM (5B8), and 
calbindin  (CL-300).  The staining  for Ng-CAM/NILE/LI, neuro- 
can, and N-CAM is most intense in the axon-rich molecular layer 
and fiber tract (the developing white matter).  Purkinje cell bodies 
and their dendritic trees and axonal projections are labeled by anti- 
bodies to calhindin. IGL, internal granule cell layer; PC, Purkinje 
cells. Bar,  10/~m. 
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Protein 1  Concentration 1  Density 1  Protein 2  Concentration  2  Density 2  Attached cells 
it  g  /ml  n  g  /mnf  ~t  g  /ml  n  &/mm  z  cells~ram  2 
Anti-Ng-CAM  30  1.50 ±  0.22  BSA  33  ND  535 ±  32 
Anti-Ng-CAM  10  0.73  ±  0.00  BSA  33  ND  286 ±  53 
BSA  33  ND  Anti-Ng-CAM  30  0.55  ±  0.06  305 ±  73 
BSA  33  ND  Anti-Ng-CAM  10  0.25  ±  0.01  221  ±  52 
Anti-Ng-CAM  30  1.50 ±  0.22  Neurocan  33  0.41  ±  0.00  386 ±  0 
Anti-Ng-CAM  10  0.73  ±  0.00  Neurocan  33  0.76 ±  0.06  0  ±  0 
Neurocan  33  1.20 +  0.04  -Anti-Ng-CAM  30  0.42  ±  0.01  1 ±  1 
Neurocan  33  1.20 ±  0.04  Anti-Ng-CAM  10  0.17  ±  0.03  0  +  0 
Cell adhesion  assays were performed using  substrates consisting  of sequentially  incubated  soluble  proteins 1 and 2 at concentrations 1 and 2, respectively. The 
resulting  surface  densities  of adsorbed protein  (densities I and 2) were determined  in parallel  experiments  using  the same sabstrate, proteins,  protein  confutations 
and liquid  volume  as in the cell adhesion assays. To determine  density 1, duplicate  samples of different  concentrations  of labeled  protein 1 (anti-Ng-CAM  and 
neurecam)  were spotted on the dish, and bound  radioactivity  was measured  as described.in  Materials  and Methods. Identical  values  of density 1 appear in the table 
when they were based on the same  experimental  point. Data  not included  in the table  indicated  that the amount  of bound  radioactivity  of protein 1 was not lowered 
by applying  a second coat with unlabeled  protein. To determine  density  2, duplicate spots of unlabeled  protein 1 were prepared first, after which labeled  protein 
2 was added end the bound  radioativity  was measured. In the parallel  cell adhesion  assays with  unlabeled  proteins, dissociated  brain  cells from  9-d chick  embryos 
were added to substrates, and the numbers  of attached cells  after an 80-min  incubation  period  were determined  as indicated  in Materials  and Methods. The number 
of cells that attached to the BSA-coated background  was 13 + 8. Data represent averages (n = 2) + mean  deviations. 
can  (Table I).  Because  neurocan does  not bind to  anti- 
Ng-CAM (data not shown), these results suggest that neuro- 
can interacts directly with the cell surface. 
These experiments also indicated that the surface density 
of 12~I-neurocan on dishes coated with different proteins in- 
cluding anti-Ng-CAM Ig (Table I)and BSA (data not shown) 
was inversely related to the amount of protein already ad- 
sorbed onto the dish.  In contrast, the level of binding of 
125I-neurocan  to  dishes  coated  first  with  Ng-CAM  was 
higher and did not vary much from the level of adsorption 
to untreated dishes (Table ID, consistent with the interpreta- 
tion that neurocan binds to Ng-CAM but not to BSA and 
anti-Ng-CAM Ig. 
When similar substrates were tested for neuronal adhe- 
sion, strong inhibition  was found with those that were coated 
first with Ng-CAM and then with high concentrations  of neu- 
rocan (Table H). In contrast to the results with anti-Ng-CAM 
substrates,  changing the order of the adsorptions (adding 
Ng-CAM after neurocan) allowed for high levels of neuronal 
binding (Table H).  This occurred even though the surface 
density of Ng-CAM was relatively low. QuaLitatively similar 
results were obtained for both neurocan and neurocan-C, al- 
though neurocan was a  somewhat more potent inhibitor. 
F_~ects of Neurocan  on Neurite Outgrowth 
A  critical aspect of neuronal development is the growth of 
processes.  We therefore studied the effects of neurocan on 
neurite growth in culture using double-coated substrates pre- 
pared essentially as described above for the neuronal adhe- 
sion experiments. A  major difference in these experiments 
was that the non-adherent  cells were not removed by washing 
after 80 min of incubation  and many cells eventually  adhered 
to substrates even in the presence of neurocan. Neurons ex- 
tended numerous processes on surfaces coated with either 
Ng-CAM or anti-Ng-CAM Ig followed by BSA,  whereas 
neurite extension was dramatically diminished on surfaces 
coated with either Ng-CAM or anti-Ng-CAM Ig followed by 
Table  II.  Adhesion  of Cells  to Dishes  Coated  with Neurocan  and Ng-CAM 
Protein 1  Concentration 1  Density 1  Protein 2  Concentration  2  Density 2  Attached cells 
~t  g  /ml  n  g  /mm  2  ~t  g  /ml  n  g  /mm  2  c  ells  /mm  2 
Ng-CAM  50  2.69  +  0.23  BSA  33  ND  395 +  9 
Ng-CAM  17  0.75  +  0.04  BSA  33  ND  474 +  3 
BSA  33  ND  Ng-CAM  50  2.54  +  0.18  427 +  11 
BSA  33  ND  Ng-CAM  17  0.87 +  0.00  392 +  20 
Ng-CAM  50  2.69  +  0.23  Neurocan  33  1.22 +  0.03  89 +  2 
Ng-CAM  17  0.75  +  0.04  Neurocan  33  1.23~ +  0.02  37 +  19 
Neurocan  33  1.2 ±  0.04  Ng-CAM  50  1.26 -I- 0.18  460 +  2 
Neurocan  33  1.2 +  0.04  Ng-CAM  17  0.38  +  0.01  393  +  7 
Ng-CAM  50  2.69  ±  0.23  Neurocan-C  33  1.18 +  0.02  183  +  15 
Ng-CAM  17  0.75  +  0.04  Neurocan-C  33  1.21  +  0.03  95 -I- 15 
Neurocan-C  33  1.15 +  0.02  Ng-CAM  50  1.05 ±  0.01  475 ±  26 
Neurocan-C  33  1.15 ±  0.02  Ng-CAM  17  0.25  -4- 0.03  529 +  14 
The number of ceUs adhering to the BSA-coated background was 20  +  3.  Data represent averages (n  =  2)  +  mean deviations. See Table I for methods. 
The Journal of Cell Biology, Volume 125,  1994  676 Figure 10. Effects of neurocan on neurite growth on Ng-CAM and anti-Ng-CAM antibodies. Substrates were  prepared by incubation first 
with 50 t~g/mi  Ng-CAM (a and b) or 10/~g/rrd monoclonal anti-Ng-CAM IgG (c and d), followed  by incubation with either 30/~g/ml 
BSA (a and c) or neurocan (b and d), as described in Materials and Methods. Brain cells from 9-d chick embryos were added to the 
substrates, and the cells were fixed after 2 d in culture and photographed under phase microscopy. Bar, 50 ~m. 
neurocan (Fig. 10). In quantitative experiments, the neurite 
length histograms for both Ng-CAM and anti-Ng-cAM sub- 
strates showed a significant fraction of neurites longer than 
20 t~m and a decreasing proportion of neurites with greater 
lengths (Fig.  11). In contrast, neurons grown on neurocan 
plus either Ng-CAM or anti-Ng-CAM had neurites mostly 
in the 0--20-t~m range, with only relatively small numbers of 
longer neurites. These results demonstrate that neurocan is 
a potent inhibitor of  neurite growth both on proteins to which 
it can bind (e.g., Ng-CAM) and on those to which it does 
not bind (e.g., anti-Ng-CAM Ig). 
Discussion 
We have characterized several functional properties of neu- 
rocan, which accounts for >20% of the soluble chondroitin 
sulfate proteoglycans in developing rat brain. The major ob- 
servations of the present study are: (a) that neurocan binds 
with high affinity to Ng-CAM and N-CAM, two of the most 
prevalent neural CAMs that play key roles in cell adhesion, 
neuronal migration, and axonal growth during development; 
(b) that these three molecules are coexpressed during critical 
stages of cerebeUar histogenesis; and (c) that neurocan in- 
hibits neuronal adhesion and neurite growth. 
Binding of  Neurocan to Neural CAMs 
Neurocan bound with high affinity  to Ng-CAM and N-CAM, 
but not to other cell surface proteins except for laminin, 
which bound much more weakly. The potential biological 
relevance of  this lower affinity  interaction is unclear because, 
in contrast to Ng-CAM and N-CAM which axe prevalent 
during brain  development,  there  is  very little lamh~ in 
brain (Jacobson, 1991). However, one must also consider the 
potential relevance of such interactions in the peripheral 
nervous  system,  where  certain  ECM  proteins  are  more 
abundant. 
The observation that the apparent dissociation constant of 
binding of  neurocan-C to Ng-CAM and N-CAM is compara- 
ble to that obtained using the full-length proteoglycan sug- 
gests that neurocan-C (which represents the COOH-terminal 
half of neurocan) contains at least one binding site for these 
neural CAMs. This region of neurocan contains several do- 
mains, some of which have been implicated in binding of 
other proteins, including two EGF-like repeats, a lectin-like 
domain, and a  complementary regulatory protein-like se- 
quence fRauch et al., 1992).  Neurocan-C contains a single 
32-kD chondroitin 4-sulfate chain that is linked at serine- 
944, whereas three additional potential chondroitin sulfate 
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from 9-d chick embryos were plated on substrates coated with 50 
t~g/nd Ng-CAM (a) or I0 ~g/ral monoclonal  anti-Ng-CAM IgG 
(b), and either 30/~g/ml BSA or 11/~g/ml neurocan, as described 
in Materials and Methods. After 2 d in vitro cultures were fixed, 
and for each bound cell the length of the longest neurite was deter- 
mined as described  in Materials  and Methods.  The histograms 
were  obtained  by  counting  the  number  of  neuritcs  with  lengths  fall- 
ing  within the indicated ranges. The values of mean neurite lengths 
+SEM expressed in ~m were: Ng-CAM, 19.3 ±  1.8 (n =  148); 
Ng-CAM + neurocan, 6.7 ±  1.1 (n -- 66); anti-Ng-CAM, 19.4 + 
1.7 (n =  89); anti-Ng-CAM +  neurocan, 6.3  +  0.9 (n --  152). 
attachment sites (only two of which are used) are present in 
the NH2-terminal portion of neurocan. The observation that 
the binding atfmity of neurocan for Ng-CAM and N-CAM 
are quite similar raises the possibility that there may be a 
binding site that is shared by these two CAMs, which contain 
multiple Ig and fibronectin type 1II domains as well as im- 
munologically similar N-linked carbohydrate epitopes (Bur- 
goon et al.,  1991; Grumet et al.,  1984b).  With respect to 
carbohydrates, it is interesting that neurocan-C contains a 
lectin-like domain and its potential role in binding to oligo- 
saccharides on neural CAMs needs to be investigated. 
Expression and Function of  Chondroitin Sulfate 
Proteoglycans in Brain 
In agreement with evidence for a functional role of  chondroi- 
tin sulfate in proteogiycans during neural development (Snow 
et al.,  1990a,  1991; Brittis et al.,  1992;  Margolis et al., 
1991), our studies also suggest a role for chondroitin sulfate 
in the function of neurocan (Figs. 6 and 7). Although little 
is known regarding the mechanism of inhibition by these 
chondroitin sulfate proteoglycans, our findings suggest that 
Ng-CAM and N-CAM may be specific neuronal receptors 
for neumcan. In furore studies it will be important to analyze 
the fimctions of  different  domains tha  t are present in nervous 
tissue proteoglycam (Margolis and Margolis, 1993), and the 
molecular  cloning  of cDNAs  for  neurocan,  phosphacan 
(Maurel et al.,  1994),  and other chondroitin sulfate pro- 
teoglycans of brain will facilitate such studies. 
Proteoglycans that have previously been identified in non- 
neural tissues may also be present in the brain. For example, 
aggrecan, which was first identified in cartilage, is present 
in rat brain (Mflev, P., R. U. Margolis and R. K. Margolis, 
unpublished results) and the primary structure of its core 
protein has regions that are homologous to domains in neu- 
rocan (Ranch et al.,  1992).  However,  the giycosylation of 
cartilage aggrecan, which has been found to inhibit neurite 
growth (Snow et al., 1990a, 1991), differs considerably from 
that of neurocan (Rauch et al.,  1991),  and there are also 
significant differences between aggrecan from chick brain 
and cartilage (Krueger et al.,  1992).  In contrast to reports 
that aggrecan has effects on neurons (Snow and Letourneau, 
1993),  our (Grumet et al.,  1993) and other (Katoh-Semba 
and Oohira, 1993) studies indicate little or no effect of carti- 
lage aggrecan. One important difference is that significant 
inhibition of neurite growth required levels of aggrecan that 
are at least an order of magnitude greater than those used in 
our experiments (Grumet et al., 1993; and "fitble  H). The de- 
pendenee of  the effects of cartilage aggrecan on the presence 
of chondroitin sulfate chains may be due to the involvement 
of these  charged glycans in proteogiycan binding,  as  we 
showed here for neurocan. Moreover, in contrast to neuro- 
can-C and neurocan, which contain only 1-3  chondroitin 
sulfate chains, cartilage aggrecan contains up to 100 of  these 
chains per molecule. In view of structural similarities and 
differences between proteoglycans from different tissues, 
and the potential functions of chondroitin sulfate, it will be 
interesting to examine the effects  of  brain aggrecan on neural 
cells. 
The  immunolocalization studies  in cerebellum demon- 
strate that neurocan, Ng-CAM/L1/NILE, and N-CAM are 
prevalent during brain  development and have extensively 
overlapping distributions. Developing cerebellar neurons ex- 
press Ng-CAM/L1/NILE and N-CAM in vitro (Grumet et 
al.,  1984a;  Rathjen and Rutishauser,  1984;  Stallcup and 
Beasley, 1985), and in situ hybridization studies demonstrate 
that neurocan mRNA is present in cerebellar granule cells 
(Milev et al.,  1993;  and Engel, M., R. U.  Margolis, and 
R. K.  Margolis, unpublished results).  Granule cells may 
therefore be major contributors to the high levels of neuro- 
can that appear in the molecular layer of developing cere- 
bellum. 
Effects of  Neurocan on Neurons 
The cellular assays employed in this study were designed to 
investigate potential mechanisms by which neurocan influ- 
ences neuronal behavior in the presence of proteins  that 
promote neuronal adhesion and neurite outgrowth. When 
anti-Ng-CAM antibodies were used as a  permissive sub- 
strate,  neurocan inhibited neuronal adhesion and neurite 
growth. Because neurocan does not bind to anti-Ng-CAM, 
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and neurite growth by interacting directly with the cell sur- 
face. The interpretation of the effects  of neurocan on the 
adhesion of neurons to Ng-CAM itself is more complex due 
to potential interactions of neurocan with both substrate- 
bound Ng-CAM and the neuronal plasma membrane. When 
Ng-CAM was used as a permissive substrate, inhibition oc- 
curred only when neurocan was added after Ng-CAM, and 
not when neurocan was coated before Ng-CAM. This effect 
was seen even when the amounts of adsorbed neurocan were 
essentially the same in both cases (Table H). 
Neurocan is also a potent inhibitor of neurite outgrowth. 
It was important to perform such experiments because in 
contrast to cell adhesion, which is usually defined in terms 
of various in vitro assays, neurite growth is a fundamental 
cellular process that can be analyzed directly both in culture 
and in situ. In the future, it will be important to determine 
how various "inhibitory" proteins (Schwab et al., 1993) in- 
teract with cells and modulate different aspects of neuronal 
behavior. These modulations may also include growth con- 
trol, insofar as a mixture of  chondroitin sulfate proteoglycans 
from brain was recently reported to inhibit progression of  the 
cell cycle in PC12 cells (Katoh-Semba and Oohira,  1993). 
The overlapping localization of neurocan with Ng-CAM/ 
L1/NILE and N-CAM, together with the effects of mixtures 
of neurocan and Ng-CAM on cells, raise the possibility of 
at least two opposing but not exclusive modes of action that 
may occur in vivo: (a) binding of neurocan to CAMs and 
other cell surface proteins results in inhibition of neuronal 
adhesion and axonai migration, consistent with the hypothe- 
sis that proteoglycans act as barriers to neuronal penetration 
(Snow et al., 1990a,b; Perris et al., 1991; Oakley and Tos- 
hey, 1991; Pindzola et al., 1993);  and (b) CAMs neutralize 
the inhibitory effects of neurocan by directly binding to it 
and/or directly by promoting neuronal adhesion and axonal 
migration. Inasmuch as there is no direct relationship be- 
tween the ability of particular proteins to promote neuronal 
adhesion and neurite growth (Lemmon et ai., 1992;  Calof 
and Lander, 1991), it is possible that the ability of axons to 
migrate may depend on the balance between adhesive effects 
of CAMs and the inhibitory effects of molecules such as neu- 
rocan. For example, cytotactin/tenascin, which inhibits neu- 
rite outgrowth from dorsal root ganglia on fibronectin and 
laminin substrates (Crossin et al., 1990),  is able to enhance 
neurite growth when neurons are  cultured on polylysine 
(Lochter et al., 1991). Hence, a'repulsive" protein could re- 
duce neurite outgrowth on a moderately adhesive substrate 
(e.g., fibronectin or laminin) by lowering the adhesivity, yet 
it could enhance outgrowth on a strongly adhesive substrate 
(e.g., polylysine) by lowering adbesivity to a level that is 
more permissive for migration. This raises the possibility 
that various patterns of cell migration may be differentially 
affected as a result of local differences in the composition of 
cell surface receptors. A classical example of differences in 
the migratory behavior of different parts of the same neuron 
can be found in the developing cerebellum, where granule 
cells extend axons (parallel fibers) that fasciculate along the 
growth surface of the molecular layer (rieh in neurocan and 
tenascin), but only their cell bodies migrate radially across 
this layer (Jacobson,  1991). 
Although it is possible that neurocan inhibits the function 
of CAMs by proteolytically inactivating them, we have not 
detected any change in the electrophoretic mobility of Ng- 
CAM following incubation in physiological buffers with neu- 
rocan (Grumet et ai.,  1993).  A more likely mechanism of 
action is that neurocan binds to the cell surface either to 
block an adhesion molecule and/or to generate a signal to 
the cell. In support of this possibility is the finding that 125I- 
neurocan binds to neurons, and FalY fragments of antibodies 
against Ng-CAM and N-CAM inhibit this binding (Milev, P., 
D. R. Friedlander, M. Grnmet, and R. U. Margolis, unpub- 
lished observations). Moreover, recent studies indicate that 
increases in intracellular calcium levels follow binding of 
ligands to these CAMs at the surface of neurons (Schuch et 
al.,  1989;  Von Bohien und Halbach et al.,  1992;  Doherty 
and Walsh, 1992) as well as binding of chondroitin sulfate 
proteoglycans to growth cones (Snow, D. M., P. Atkinson, 
T. Hassinger, S. B. Kater, and P. C. Letourneau. 1993. Soc. 
Neurosci. Abstr. 19:876), and suggest that binding of neuro- 
can to neural CAMs may generate signals that influence ceLl 
behavior. 
It is clear that additional studies are needed to define more 
precisely the molecular mechanisms of action of neurocan 
and other chondroitin sulfate proteoglycans in the nervous 
system. Nevertheless, our results indicate that whether a par- 
ticular region of tissue will or will not be favorable for cell 
adhesion and axonal growth will depend not only on the rela- 
tive amounts of the CAMs and proteoglycans, but also on 
their sequences of expression and organization during devel- 
opment. 
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